Evan Anderson, CEO and Board Member of Luma Therapeutics, was featured in episode 5 of The Health Technology Podcast from the Rosenman Institute. In the interview, Evan discusses why he founded Luma Therapeutics and the illuvinate System, a revolutionary light therapy for those suffering from psoriasis.

Visit their website to listen to the full podcast.

About The Rosenman Institute

A nonprofit initiative at UC San Francisco. Our mission is to drive innovation and improve patient care by helping health technology entrepreneurs develop technologies from concept to commercialization.